What is CELU's gross margin?

Celularity (CELU) has a gross margin of 72% and a net margin of 18%.

What is CELU's P/E ratio?

Track Celularity (CELU) P/E ratio, ROE, and valuation metrics over time.

Where can I see CELU's full financials?

See Celularity (CELU) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Celularity (CELU) Financials — Revenue, Earnings, Cash Flow

Also trades as: GXGX (NASDAQ) · $vol 6M · GXGXW (NASDAQ) · $vol 0M · CELUW (NASDAQ) · $vol 0M

$1.60

+0.22 (+15.94%)

Weekly Expected Move ±15.4%

$1 $1 $2 $2 $2

NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 49 · $46.3M mcap · 19M float · 0.714% daily turnover · Short 68% of daily vol

📊 Key Metrics

TTM

$19M

Revenue

-62.8% YoY

$-71M

Net Income

-28.1% YoY

$-9M

Free Cash Flow

-72.4% YoY

72.5%

Gross Margin

-263.5%

Op. Margin

17.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE349.7%

ROA-62.4%

ROIC-195.2%

Valuation

P/E-0.6

P/B-1.3

EV/EBITDA-1.4

Leverage

Debt/Equity-1.71

Current Ratio0.09

Interest Cov.-17.1x

Quality Scores

Piotroski F2/9

Altman Z-16.59

Beneish M-6.33